On August 20, 2008, China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) (the “Company”) announced it would be restating its financial statements for the fiscal periods ended June 30, September 30, and December 30, 2007 and fiscal quarter ended March 31, 2008.  The Company’s share price dropped dramatically on this news, losing 18% of its value the day after the restatement was announced.

Finkelstein Thompson LLP welcomes inquiries from the Company’s shareholders concerning their rights and interests in connection with this matter. Interested shareholders can reach Finkelstein Thompson LLP’s Washington, D.C. office at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it